Related Experiment Video
Updated: Jun 27, 2026
08:23
Single Cell Transcriptional Profiling of Adult Mouse Cardiomyocytes
Published on: December 28, 2011
CD36 expression contributes to age-induced cardiomyopathy in mice
Debby P Y Koonen1, Maria Febbraio, Sebastien Bonnet
1Cardiovascular Research Group, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada T6G 2S2.
Circulation
|October 31, 2007
Summary
Aging hearts accumulate lipids and reduce energy production, leading to impaired function. The fatty acid transporter CD36 mediates these age-related cardiac changes in mice.
Area of Science:
- Cardiology
- Metabolic research
- Aging research
Background:
- Aging is linked to cardiac remodeling and decreased heart function, increasing heart disease risk.
- While vascular factors contribute, myocardium-specific changes in aging hearts are also implicated.
Purpose of the Study:
- To investigate the role of intramyocardial metabolic alterations in age-related cardiac dysfunction.
- To determine the involvement of the fatty acid transporter CD36 in these changes.
Main Methods:
- Comparative analysis of cardiac metabolism, function, and structure in young and aged mice.
- Assessment of CD36 expression and its impact using CD36-deficient aged mice.
Main Results:
- Aged mice exhibit intramyocardial lipid accumulation, reduced fatty acid and glucose oxidation, and decreased ATP production.
- Hearts from aged mice show depressed performance and hypertrophy, associated with increased CD36 expression.
- Aged CD36-deficient mice display reduced lipid accumulation, improved ATP production, enhanced cardiac function, and blunted hypertrophy compared to aged wild-type mice.
Conclusions:
- CD36 mediates age-induced cardiomyopathy in mice.
- Inhibiting CD36 may offer a therapeutic strategy for age-related cardiac decline.
